TEAS RF New Application

TARIS BIO

TARIS BIOMEDICAL LLC

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88509350
Filing Date: 07/11/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88509350
MARK INFORMATION
*MARK TARIS BIO
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TARIS BIO
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK TARIS BIOMEDICAL LLC
*STREET 113 Hartwell Avenue
*CITY Lexington
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02421
LEGAL ENTITY INFORMATION
TYPE limited liability company
STATE/COUNTRY WHERE LEGALLY ORGANIZED Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical products, namely, preparations to treat genitourinarytract and urological disorders
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Research and development of pharmaceuticals and therapeutics; Pharmaceutical products development
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 5161837, 4318234, and 3842656.
ATTORNEY INFORMATION
NAME Jessica S. Parise
ATTORNEY DOCKET NUMBER CER-613
FIRM NAME Goodwin Procter LLP
INTERNAL ADDRESS The New York Times Building
STREET 620 Eighth Avenue
CITY New York
STATE New York
COUNTRY United States
ZIP/POSTAL CODE 10018
PHONE 212-813-8800
FAX 212-355-3333
EMAIL ADDRESS TMadmin@goodwinlaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Steven R. Argentieri, Stephen G. Charkoudian, Robert M. Crawford, Jr., Joel E. Lehrer, Jeffrey Rummler, Gessingga N. Storer, Bethany P. Withers, Adam M. Chud, Kevin V. Lam, Ira J. Levy, Achal Oza, Jessica Rothstein, Alexandra M. Vaccaro
CORRESPONDENCE INFORMATION
NAME Jessica S. Parise
FIRM NAME Goodwin Procter LLP
INTERNAL ADDRESS The New York Times Building
STREET 620 Eighth Avenue
CITY New York
STATE New York
COUNTRY United States
ZIP/POSTAL CODE 10018
PHONE 212-813-8800
FAX 212-355-3333
*EMAIL ADDRESS TMadmin@goodwinlaw.com; JParise@goodwinlaw.com; SAlliRampersad@goodwinlaw.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 550
*TOTAL FEE PAID 550
SIGNATURE INFORMATION
SIGNATURE /Cheryl Larrivee-Elkins/
SIGNATORY'S NAME Cheryl Larrivee-Elkins
SIGNATORY'S POSITION Chief Compliance Officer
SIGNATORY'S PHONE NUMBER 781-541-4076
DATE SIGNED 07/11/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88509350
Filing Date: 07/11/2019

To the Commissioner for Trademarks:

MARK: TARIS BIO (Standard Characters, see mark)
The literal element of the mark consists of TARIS BIO.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, TARIS BIOMEDICAL LLC, a limited liability company legally organized under the laws of Delaware, having an address of
      113 Hartwell Avenue
      Lexington, Massachusetts 02421
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical products, namely, preparations to treat genitourinarytract and urological disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 042:  Research and development of pharmaceuticals and therapeutics; Pharmaceutical products development
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 5161837, 4318234, and 3842656.

The applicant's current Attorney Information:
      Jessica S. Parise and Steven R. Argentieri, Stephen G. Charkoudian, Robert M. Crawford, Jr., Joel E. Lehrer, Jeffrey Rummler, Gessingga N. Storer, Bethany P. Withers, Adam M. Chud, Kevin V. Lam, Ira J. Levy, Achal Oza, Jessica Rothstein, Alexandra M. Vaccaro of Goodwin Procter LLP
      The New York Times Building
      620 Eighth Avenue
      New York, New York 10018
      United States
      212-813-8800(phone)
      212-355-3333(fax)
      TMadmin@goodwinlaw.com (authorized)
The attorney docket/reference number is CER-613.

The applicant's current Correspondence Information:
      Jessica S. Parise
      Goodwin Procter LLP
      The New York Times Building
      620 Eighth Avenue
      New York, New York 10018
      212-813-8800(phone)
      212-355-3333(fax)
      TMadmin@goodwinlaw.com;JParise@goodwinlaw.com; SAlliRampersad@goodwinlaw.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Cheryl Larrivee-Elkins/   Date: 07/11/2019
Signatory's Name: Cheryl Larrivee-Elkins
Signatory's Position: Chief Compliance Officer
Payment Sale Number: 88509350
Payment Accounting Date: 07/11/2019

Serial Number: 88509350
Internet Transmission Date: Thu Jul 11 10:43:36 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20190711104336369
394-88509350-62093c6696f3fbc56d818617b62
c42aa2788dcac31f53568e6b4398d037b02f2035
-CC-11623-20190703120150263854

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed